Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Psychedelics and psychedelic-assisted psychotherapy
Work Group on Biomarkers and Novel Treatments
, Division of the American Psychiatric Association Council of Research
Psychiatry & Behavioral Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
474
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Psychedelics and psychedelic-assisted psychotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Psychiatric Disorders
100%
Lysergic Acid Diethylamide
100%
Psychedelic Therapy
100%
3,4-methylenedioxymethamphetamine
100%
Psychedelics
100%
Psilocybin
80%
Ayahuasca
80%
Clinical Trials
40%
Clinical Application
40%
Posttraumatic Stress Disorder
40%
Human Subjects
20%
Depression Treatment
20%
Evidence-based
20%
Cancer Treatment
20%
Therapeutic Effect
20%
Mood Disorders
20%
Cancer-related
20%
Randomized Clinical Trial
20%
U.S. Food
20%
Anxiety Disorders
20%
Treatment-resistant Depression
20%
Peer-reviewed Journals
20%
Ovid
20%
Substance-related Disorders
20%
PubMed
20%
End-of-life Care
20%
Stress Treatment
20%
Stress Disorders
20%
PsycINFO
20%
Addictive Disorders
20%
Breakthrough Therapy
20%
Trauma Symptoms
20%
Pharmacology, Toxicology and Pharmaceutical Science
MDMA
100%
Psychotomimetic
100%
Lysergide
100%
Psilocybin
80%
Clinical Trial
40%
Posttraumatic Stress Disorder
40%
Mood Disorder
20%
Randomized Clinical Trial
20%
Malignant Neoplasm
20%
Therapeutic Effect
20%
Anxiety Disorder
20%
Treatment Resistant Depression
20%
Homo sapiens
20%